Search Count: 6
 |
Crystal Structure Of An Acidic Ph-Selective Ipilimumab Variant Ipi.105 In Complex With Ctla-4
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2022-03-02 Classification: IMMUNE SYSTEM Ligands: NAG, FLC, PEG |
 |
Crystal Structure Of An Acidic Ph-Selective Ipilimumab Variant Ipi.106 In Complex With Ctla-4
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2022-03-02 Classification: IMMUNE SYSTEM Ligands: NAG |
 |
Factor Xia In Complex With The Inhibitor 4-[[(2~{S},3~{R})-1-[(~{E})-3-[5-Chloranyl-2-(1,2,3,4-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl]-3-Phenyl-Pyrrolidin-2-Yl]Carbonylamino]Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.64 Å Release Date: 2017-11-08 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: BUV, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor 4-[[(1~{S})-2-[(~{E})-3-[5-Chloranyl-2-(1,2,3,4-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl]-3,4-Dihydro-1~{H}-Isoquinolin-1-Yl]Carbonylamino]Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2017-11-08 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: BUY, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl ~{N}-[4-[[(1~{S})-2-[(~{E})-3-[3-Chloranyl-2-Fluoranyl-6-(1,2,3,4-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl]-3,4-Dihydro-1~{H}-Isoquinolin-1-Yl]Carbonylamino]Phenyl]Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2017-11-08 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: BVJ, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor 4-[[(1~{S})-2-[(~{E})-3-[5-Chloranyl-2-(1,2,3,4-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl]-5-[(3~{S})-3-Ethoxycarbonylpiperidin-1-Yl]Carbonyl-3,4-Dihydro-1~{H}-Isoquinolin-1-Yl]Carbonylamino]Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2017-11-08 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: BVM, SO4, EDO |